Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.79M Buy
+4,831
New +$4.94M 0.72% 52
2024
Q1
Sell
-4,967
Closed -$2.89M 74
2023
Q4
$2.89M Hold
4,967
0.57% 56
2023
Q3
$2.72M Hold
4,967
0.58% 54
2023
Q2
$2.31M Hold
4,967
0.48% 61
2023
Q1
$1.69M Hold
4,967
0.39% 71
2022
Q4
$1.83M Sell
4,967
-5,830
-54% -$2.07M 0.42% 67
2022
Q3
$3.56M Hold
10,797
0.82% 41
2022
Q2
$3.47M Hold
10,797
0.76% 45
2022
Q1
$3.07M Hold
10,797
0.54% 53
2021
Q4
$2.98M Hold
10,797
0.49% 57
2021
Q3
$2.5M Hold
10,797
0.46% 59
2021
Q2
$2.48M Hold
10,797
0.44% 60
2021
Q1
$2.02M Hold
10,797
0.42% 60
2020
Q4
$1.82M Buy
10,797
+962
+10% +$144K 0.41% 60
2020
Q3
$1.46M Hold
9,835
0.5% 45
2020
Q2
$1.61M Buy
+9,835
New +$1.51M 0.66% 43

Other funds holding LLY

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet's LLY Position: Q2 2026 in Review

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet opened a new position in Eli Lilly (LLY) in Q2 2026: 4,831 shares worth $5.79M. The stake represents 0.72% of the portfolio and ranks #52 among its holdings. This is a return to the name: Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet previously reported a position in LLY as recently as Q4 2023.

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet first reported a position in LLY in Q2 2020 and has held it in 16 quarters since. 3,689 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet held 4,831 shares of Eli Lilly worth $5.79M as of Q2 2026.
  • Eli Lilly was a new Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet position in Q2 2026.
  • Eli Lilly made up 0.72% of Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet's portfolio in Q2 2026, its #52 holding.
  • Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet first reported a position in Eli Lilly in Q2 2020 and has held it in 16 quarters since.
  • 3,689 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet's 13F filing for Q2 2026, filed 5 Aug 2026.